Inhibitory effects of KAT-681, a liver-selective thyromimetic, on development of hepatocellular proliferative lesions in rats induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation

By Hayashi Morimichi  

Archives of Toxicology, Vol. 78, Iss. 8, 2004-08 ,pp. : 460-466

Springer Publishing Company

Access to resources Recommend Favorite

Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks

By Kataoka Yu  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1352-1360

Springer Publishing Company

Access to resources Recommend Favorite

Novel Aglycones of Steroidal Glycoalkaloids as Potent Tyrosine Kinase Inhibitors: Role in VEGF and EGF Receptors Targeted Angiogenesis

By  

Letters in Drug Design & Discovery, Vol. 8, Iss. 3, 2011-03 ,pp. : 205-215

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of ketoconazole or rifampin on the pharmacokinetics of tivozanib hydrochloride, a vascular endothelial growth factor receptor tyrosine kinase inhibitor

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 2, 2015-03 ,pp. : 137-142

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impaired liver regeneration after partial hepatectomy in db/db mice

By Yamauchi Hirofumi   Uetsuka Koji   Okada Taro   Nakayama Hiroyuki   Doi Kunio  

Experimental and Toxicologic Pathology, Vol. 54, Iss. 4, 2003-03 ,pp. : 281-286

Urban & Fischer

Access to resources Recommend Favorite